ijms-logo

Journal Browser

Journal Browser

Role of Different Metabolic Pathways on Development and Progression of Cancer

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: closed (29 February 2024)

Special Issue Editors


E-Mail Website
Guest Editor
Professor of Molecular Medicine, Bose Institute, Kolkata, India
Interests: Oragan Pathophysiology; Cellular signalling; Cancer Biology; Bioactive natural products; Nanoparticle mediated drug delivery

E-Mail Website
Guest Editor
Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA
Interests: Cancer signaling; Cancer immunology; Cancer metabolism; Targeted therapy; Repurposed drugs
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Metabolic pathways play a critical role in the development and progression of cancer. Cancer cells undergo various alterations in their metabolism in order to support their rapid growth, proliferation, and survival. These alterations are collectively referred to as cancer metabolism or the "Warburg effect," named after Otto Warburg, who observed enhanced glucose consumption and lactate production in cancer cells.

Some of the key metabolic pathways involved in cancer are as follows:

  1. Glycolysis: Cancer cells often exhibit increased glucose uptake and rely heavily on glycolysis, even under aerobic conditions (the Warburg effect). Glycolysis breaks down glucose into pyruvate, producing a small quantity of ATP and NADH.
  2. Pentose phosphate pathway (PPP): The PPP generates ribose-5-phosphate and NADPH, which are essential for nucleotide and lipid synthesis, respectively. NADPH also plays a crucial role in maintaining redox balance and protecting cancer cells from oxidative stress.
  3. Tricarboxylic Acid (TCA) Cycle: Also known as the Krebs cycle or citric acid cycle, the TCA cycle generates ATP and provides intermediates for other biosynthetic pathways. Cancer cells may rewire the TCA cycle to support the synthesis of macromolecules required for rapid cell division.
  4. Glutaminolysis: Glutamine is a vital for cancer cells. It is taken up by cancer cells and converted to glutamate via a series of reactions known as glutaminolysis. Glutamate can then be used to generate ATP, contribute to nucleotide synthesis, and produce antioxidants.
  5. Lipid metabolism: Cancer cells require an adequate supply of lipids for membrane synthesis and signaling. They may upregulate de novo lipogenesis (synthesis of fatty acids) and increase lipid uptake from the environment.
  6. Amino acid metabolism: Cancer cells have increased amino acid requirements to support protein synthesis and various metabolic pathways. They may upregulate amino acid transporters and enzymes involved in amino acid metabolism.
  7. Mitochondrial metabolism: Cancer cells can exhibit alterations in mitochondrial function. In some cases, they rely less on oxidative phosphorylation (OXPHOS) and more on glycolysis for energy production (the Warburg effect). However, some cancers still retain functional mitochondria and rely on OXPHOS for ATP generation.

Understanding the metabolic pathways in cancer has led to the development of targeted therapies. For example, drugs that inhibit specific enzymes or transporters involved in cancer metabolism have been developed in order to selectively disrupt cancer cell growth and survival.

In this Special Issue, we will discuss the various critical metabolic pathways that occur in cancer progression. We will also discuss the therapeutic potential of targeting metabolic pathways in order to enhance overall survival and disease-free survival.

Prof. Dr. Parames C. Sil
Dr. Pritam Sadhukhan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolic regulation in cancer
  • metabolic reprogramming in cancer
  • targeted therapy in cancer
  • tumour metabolism

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop